Groowe Groowe / Newsroom / KROS
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

KROS News

Keros Therapeutics, Inc. Common Stock

Keros Therapeutics Announces Plan for Return of $375 Million in Excess Capital

globenewswire.com
KROS

ADAR1 Sends Open Letter to Keros Board of Directors Urging the Board to Engage Constructively on Strategy, Capital Allocation and Board Refreshment

prnewswire.com
KROS